Organization · Venture Capital
Pureos Bioventures
Pureos Bioventures is a Swiss venture capital firm focused on investing in private companies developing innovative drug therapies. It primarily targets the biopharmaceutical sector in Europe, particularly Switzerland.
Overview
What Pureos Bioventures does
What Pureos Bioventures is
Pureos Bioventures is a Swiss venture capital firm focused on investing in private companies developing innovative drug therapies. It primarily targets the biopharmaceutical sector in Europe, particularly Switzerland.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- April 22, 2026
Official channels
Find Pureos Bioventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Pureos Bioventures as a funder
Investment thesis
Pureos Bioventures invests in private companies focused on innovative drug development, particularly in the biopharmaceutical sector, emphasizing next-generation biological drugs aimed at treating severe diseases.
Focus narrative
Pureos Bioventures specializes in investing in companies that are developing innovative therapeutics within the biopharmaceutical sector. Their investment strategy is centered around backing clinical-stage and preclinical companies that are working on groundbreaking treatments for severe diseases, including cancer and fibrotic conditions. The firm seeks to support the advancement of next-generation biological drugs and drug formats.
Value beyond capital
Pureos Bioventures adds value to its portfolio companies by providing operational support to accelerate clinical development, leveraging the clinical operations expertise of its general partner team. The firm often co-leads investment rounds, ensuring that its portfolio companies receive not only financial backing but also strategic guidance and industry connections to enhance their growth and success.
Focus and fit
- Stages
- Series A · Series B · Series C · Growth Equity
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 33
- Recorded notable exits
- Araris Biotech, LAVA Therapeutics, and Imcheck Therapeutics
Portfolio context
Notable portfolio companies include: Acrivon Therapeutics: A clinical-stage oncology company developing novel cancer drugs with companion diagnostics. Adcytherix: Focused on antibody drug conjugates for cancer treatment. Alentis Therapeutics: Developing treatments for cancer and fibrotic diseases. AM Pharma: Focused on recombinant human Alkaline Phosphatase for acute kidney injury. Corlieve Therapeutics: Focused on therapies for neurological diseases, acquired by uniQure. Hummingbird Bioscience: Developing precision monoclonal antibodies for cancer. ImCheck Therapeutics: Developing antibody therapeutics targeting immune checkpoints, acquired by Ipsen. PulseSight Therapeutics: Developing non-viral gene therapies for ophthalmology.
Common questions
What to know about Pureos Bioventures
Upseed classifies Pureos Bioventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 22, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.